Early Levodopa-Induced Motor Complications in RAB39B X-Linked Parkinsonism

Laurane Mackels; David Aktan; Frédérique Depierreux

doi:10.5334/tohm.946

Abstract

Background: While levodopa may benefit some patients with monogenic Parkinson’s Disease and parkinsonism, others may exhibit aberrant responses earlier after exposure. Reporting treatment responses in rare genetic parkinsonism will help tailor therapeutic approaches to specific patients subpopulations.

Case Report: We report the therapeutic response in a patient with RAB39B X-linked parkinsonism, who exhibited motor and non-motor complications within a few months of Levodopa.

Discussion: Severe and debilitating Levodopa-induced complications can occur very early in the treatment course of X-linked parkinsonism, highlighting the need for an individualized therapeutic approach and follow-up in rare parkinsonian syndromes.

References

Rajput A, et al. Levodopa efficacy and pathological basis of Parkinson syndrome. Clinical neuropharmacology. 1990; 13(6): 553–558. DOI: 10.1097/00002826-199012000-00007
Open DOI Search in Google Scholar Back to article
Rajput AH, et al. Clinical–pathological study of levodopa complications. Movement disorders: official journal of the Movement Disorder Society. 2002; 17(2): 289–296. DOI: 10.1002/mds.10031
Open DOI Search in Google Scholar Back to article
Guadagnolo D, et al. Genotype-phenotype correlations in monogenic Parkinson disease: A review on clinical and molecular findings. Frontiers in Neurology. 2021; 12: 648588. DOI: 10.3389/fneur.2021.648588
Open DOI Search in Google Scholar Back to article
Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. The Lancet Neurology. 2006; 5(4): 355–363. DOI: 10.1016/S1474-4422(06)70411-2
Open DOI Search in Google Scholar Back to article
Wickremaratchi M, Ben-Shlomo Y, Morris HR. The effect of onset age on the clinical features of Parkinson’s disease. European journal of neurology. 2009; 16(4): 450–456. DOI: 10.1111/j.1468-1331.2008.02514.x
Open DOI Search in Google Scholar Back to article
Mackels L, Moïse M, Depierreux F. Multimodal imaging of a patient with RAB39B mutation. Neuroradiology. 2022; 64(3): 621–625. DOI: 10.1007/s00234-021-02882-w
Open DOI Search in Google Scholar Back to article
Riboldi GM, et al. A practical approach to early-onset parkinsonism. Journal of Parkinson’s disease. 2022; 12(1): 1–26. DOI: 10.3233/JPD-212815
Open DOI Search in Google Scholar Back to article
Wilson GR, et al. Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology. The American Journal of Human Genetics. 2014; 95(6): 729–735. DOI: 10.1016/j.ajhg.2014.10.015
Open DOI Search in Google Scholar Back to article
Fahn S. Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Archives of neurology. 1999; 56(5): 529–535. DOI: 10.1001/archneur.56.5.529
Open DOI Search in Google Scholar Back to article
Kieburtz K. Therapeutic strategies to prevent motor complications in Parkinson’s disease. Journal of neurology. 2008; 255: 42–45. DOI: 10.1007/s00415-008-4007-4
Open DOI Search in Google Scholar Back to article
Cilia R, et al. The modern pre-levodopa era of Parkinson’s disease: insights into motor complications from sub-Saharan Africa. Brain. 2014; 137(10): 2731–2742. DOI: 10.1093/brain/awu195
Open DOI Search in Google Scholar Back to article
Camerucci E, et al. Early-Onset Parkinsonism and Early-Onset Parkinson’s Disease: A Population-Based Study (2010–2015). J Parkinsons Dis. 2021; 11(3): p. 1197–1207. DOI: 10.3233/JPD-202464
Open DOI Search in Google Scholar Back to article
Turcano P, et al. Levodopa-induced dyskinesia in Parkinson disease: a population-based cohort study. Neurology. 2018; 91(24): e2238–e2243. DOI: 10.1212/WNL.0000000000006643
Open DOI Search in Google Scholar Back to article
Mehanna R, et al. Comparing clinical features of young onset, middle onset and late onset Parkinson’s disease. Parkinsonism & related disorders. 2014; 20(5): 530–534. DOI: 10.1016/j.parkreldis.2014.02.013
Open DOI Search in Google Scholar Back to article
Kostic V, et al. Early development of levodopa-induced dyskinesias and response fluctuations in young-onset Parkinson’s disease. Neurology. 1991; 41(2 Part 1): 202–202. DOI: 10.1212/WNL.41.2_Part_1.202
Open DOI Search in Google Scholar Back to article
Leaver K, et al. Clinical profiles and outcomes of deep brain stimulation in G2019S LRRK2 Parkinson disease. Journal of Neurosurgery. 2022; 137(1): 184–191. DOI: 10.3171/2021.7.JNS21190
Open DOI Search in Google Scholar Back to article
Kuusimäki T, et al. Deep brain stimulation for monogenic Parkinson’s disease: a systematic review. Journal of Neurology. 2020; 267: 883–897. DOI: 10.1007/s00415-019-09181-8
Open DOI Search in Google Scholar Back to article
Artusi CA, et al. Association of subthalamic deep brain stimulation with motor, functional, and pharmacologic outcomes in patients with monogenic Parkinson disease: a systematic review and meta-analysis. JAMA network open. 2019; 2(2): e187800–e187800. DOI: 10.1001/jamanetworkopen.2018.7800
Open DOI Search in Google Scholar Back to article
Laxova R, et al. An X-linked recessive basal ganglia disorder with mental retardation. American journal of medical genetics. 1985; 21(4): 681–689. DOI: 10.1002/ajmg.1320210409
Open DOI Search in Google Scholar Back to article
Gregg RG, et al. Waisman syndrome, a human X-linked recessive basal ganglia disorder with mental retardation: localization to Xq27. 3-qter. Genomics. 1991; 9(4): 701–706. DOI: 10.1016/0888-7543(91)90363-J
Open DOI Search in Google Scholar Back to article
Lesage S, et al. Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease. Neurology Genetics. 2015; 1(1). DOI: 10.1212/NXG.0000000000000009
Open DOI Search in Google Scholar Back to article
Mata IF, et al. The RAB39B p. G192R mutation causes X-linked dominant Parkinson’s disease. Molecular neurodegeneration. 2015; 10(1): 1–8. DOI: 10.1186/s13024-015-0045-4
Open DOI Search in Google Scholar Back to article
Shi Ch, et al. A novel RAB39B gene mutation in X-linked juvenile parkinsonism with basal ganglia calcification. Movement Disorders. 2016; 31(12): 1905–1909. DOI: 10.1002/mds.26828
Open DOI Search in Google Scholar Back to article
Ciammola A, et al. X-linked Parkinsonism with Intellectual Disability caused by novel mutations and somatic mosaicism in RAB39B gene. Parkinsonism & Related Disorders. 2017; 44: 142–146. DOI: 10.1016/j.parkreldis.2017.08.021
Open DOI Search in Google Scholar Back to article
Güldner M, et al. Broad clinical phenotype in Parkinsonism associated with a base pair deletion in RAB39B and additional POLG variant. Parkinsonism & Related Disorders. 2016; 31: 148–150. DOI: 10.1016/j.parkreldis.2016.07.005
Open DOI Search in Google Scholar Back to article

Early Levodopa-Induced Motor Complications in RAB39B X-Linked Parkinsonism

Abstract

Paradigm

My account